Zhou et al., 2018 - Google Patents
A Macaca fascicularis knee osteoarthritis model developed by modified Hulth combined with joint scratchesZhou et al., 2018
View HTML- Document ID
- 198837118076525996
- Author
- Zhou X
- Zhang L
- Guo X
- Liu G
- Wang G
- Fu S
- Publication year
- Publication venue
- Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
External Links
Snippet
Background Osteoarthritis is a common degenerative disease of joints, and animal models have important significance in the investigation of this disease. The aim of this study was to develop a better method for developing osteoarthritis models in primates by comparing the …
- 201000008482 osteoarthritis 0 title abstract description 105
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Salzmann et al. | Autologous minced cartilage implantation for treatment of chondral and osteochondral lesions in the knee joint: an overview | |
| Suri et al. | Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis | |
| Minas et al. | Current concepts in the treatment of articular cartilage defects | |
| Hart et al. | Platelet-rich plasma in patients with tibiofemoral cartilage degeneration | |
| Selmi et al. | Autologous chondrocyte implantation in a novel alginate-agarose hydrogel: outcome at two years | |
| Farr et al. | Clinical cartilage restoration: evolution and overview | |
| Abrams et al. | Platelet-rich plasma for articular cartilage repair | |
| Yausep et al. | Platelet rich plasma for treatment of osteochondral lesions of the talus: a systematic review of clinical trials | |
| Borazjani et al. | Effect of impact on chondrocyte viability during insertion of human osteochondral grafts | |
| Xing et al. | Intra-articular injection of mesenchymal stem cells in treating knee osteoarthritis: a systematic review of animal studies | |
| Kon et al. | Subchondral and intra‐articular injections of bone marrow concentrate are a safe and effective treatment for knee osteoarthritis: a prospective, multi‐center pilot study | |
| Chahla et al. | Biological therapies for cartilage lesions in the hip: a new horizon | |
| Akpancar et al. | Comparison of platelet rich plasma and prolotherapy in the management of osteochondral lesions of the talus: a retrospective cohort study | |
| Song et al. | High tibial osteotomy with human umbilical cord blood-derived mesenchymal stem cells implantation for knee cartilage regeneration | |
| Wang et al. | Interleukin‐17 Can Induce Osteoarthritis in Rabbit Knee Joints Similar to Hulth’s Method | |
| Chahla et al. | Bone marrow aspirate concentrate for orthopaedic use | |
| CN101505787B (en) | Treatment of cartilage disorders | |
| Zhou et al. | A Macaca fascicularis knee osteoarthritis model developed by modified Hulth combined with joint scratches | |
| Pan et al. | Delivery of epidermal growth factor receptor inhibitor via a customized collagen scaffold promotes meniscal defect regeneration in a rabbit model | |
| Elghawy et al. | Osteochondral defects of the talus with a focus on platelet-rich plasma as a potential treatment option: a review | |
| Yoshida et al. | Treatment of partial growth arrest using an in vitro-generated scaffold-free tissue-engineered construct derived from rabbit synovial mesenchymal stem cells | |
| Borrelli Jr et al. | Cartilage tolerates single impact loads of as much as half the joint fracture threshold. | |
| Goyal | Recent advances and future trends in articular cartilage repair | |
| Tamaddon et al. | Sheep condyle model evaluation of bone marrow cell concentrate combined with a scaffold for repair of large osteochondral defects | |
| Migliorini et al. | Management of knee osteoarthritis using bone marrow aspirate concentrate: a systematic review |